| Basics |
Coherus BioSciences, Inc.
Coherus BioSciences Inc is a biotechnology company that develops biosimilar therapeutics. The company seeks to ensure successful drug development and manufacturing under very aggressive timelines.
|
| IPO Date: |
November 6, 2014 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$149.93M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.39 | 3.09%
|
| Avg Daily Range (30 D): |
$0.04 | 3.72%
|
| Avg Daily Range (90 D): |
$0.03 | 3.40%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.1M |
| Avg Daily Volume (30 D): |
1.37M |
| Avg Daily Volume (90 D): |
1.25M |
| Trade Size |
| Avg Trade Size (Sh.): |
152 |
| Avg Trade Size (Sh.) (30 D): |
351 |
| Avg Trade Size (Sh.) (90 D): |
335 |
| Institutional Trades |
| Total Inst.Trades: |
3,191 |
| Avg Inst. Trade: |
$1.5M |
| Avg Inst. Trade (30 D): |
$.69M |
| Avg Inst. Trade (90 D): |
$.69M |
| Avg Inst. Trade Volume: |
.13M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.76M |
| Avg Closing Trade (30 D): |
$2.58M |
| Avg Closing Trade (90 D): |
$2.58M |
| Avg Closing Volume: |
158.54K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$1.55
|
$2.57
|
$-.49
|
|
Diluted EPS
|
$1.59
|
$2.57
|
$-.49
|
|
Revenue
|
$ 142.77M
|
$ 10.25M
|
$ 7.6M
|
|
Gross Profit
|
$ 82.12M
|
$ 6.86M
|
$ 4.95M
|
|
Net Income / Loss
|
$ 179.75M
|
$ 297.77M
|
$ -56.57M
|
|
Operating Income / Loss
|
$ -139.55M
|
$ -45.49M
|
$ -45.44M
|
|
Cost of Revenue
|
$ 60.65M
|
$ 3.4M
|
$ 2.65M
|
|
Net Cash Flow
|
$ 57.46M
|
$ 134.48M
|
$ -43.58M
|
|
PE Ratio
|
0.82
|
|
|
|
|
|
